Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 18674045 | DRUG DELIVERY DEVICE FOR DELIVERING AT LEAST ONE DRUG, OPTIONALLY AT LEAST ONE RECONSTITUTED DRUG, MEDICAL DEVICE AND MEDICAL SYSTEM | May 2024 | March 2026 | Allow | 22 | 4 | 0 | Yes | No |
| 18014566 | DOSE SETTING SENSOR ASSEMBLY WITH ALGORITHMIC AUTO CALIBRATION | January 2023 | January 2026 | Abandon | 36 | 0 | 1 | No | No |
| 17954840 | SAFETY CAP | September 2022 | January 2026 | Allow | 40 | 1 | 1 | Yes | No |
| 17878403 | NEEDLE INSERTION MECHANISM FOR AN INJECTION DEVICE WITH AN IMPROVED IMPACT RESISTANCE | August 2022 | March 2026 | Allow | 43 | 1 | 1 | Yes | No |
| 17764828 | PATIENT-MAINTAINED SEDATION | March 2022 | February 2026 | Abandon | 47 | 2 | 0 | Yes | No |
| 17627008 | SEALING ARRANGEMENT FOR DRUG DELIVERY DEVICE | January 2022 | March 2026 | Abandon | 50 | 2 | 1 | No | No |
| 17574127 | Vascular Access Instrument Advancement Devices, Systems, and Methods | January 2022 | September 2025 | Allow | 45 | 4 | 0 | No | No |
| 17626012 | STATE DETECTOR ARRANGEMENT FOR STATE DETECTION OF A MEDICAMENT DELIVERY DEVICE | January 2022 | November 2025 | Abandon | 46 | 1 | 1 | No | No |
| 17570566 | Probe Delivery Device to Facilitate Advancement of a Probe Within an Intravenous Catheter | January 2022 | July 2025 | Allow | 42 | 1 | 1 | Yes | No |
| 17569965 | WEARABLE DRUG DELIVERY DEVICE WITH REMOVAL ELEMENT | January 2022 | August 2025 | Allow | 43 | 4 | 1 | Yes | No |
| 17557924 | Fluid Path Optimization in Catheter Insertion Systems | December 2021 | December 2024 | Allow | 36 | 3 | 0 | Yes | Yes |
| 17551278 | INTRAVENOUS CANNULA | December 2021 | October 2025 | Allow | 46 | 5 | 0 | Yes | No |
| 17596457 | Method And Device For Substance Delivery To The Inner Ear | December 2021 | December 2025 | Abandon | 48 | 1 | 1 | No | No |
| 17547804 | Wire and Catheter Organizer for Endovascular Procedure | December 2021 | May 2025 | Allow | 41 | 5 | 0 | Yes | No |
| 17540805 | LOW DEADSPACE SYRINGE INCLUDING A PIVOTING NEEDLE GUARD | December 2021 | July 2025 | Abandon | 43 | 1 | 0 | No | No |
| 17532921 | RADIOPAQUE MARKER AND DELIVERY SYSTEM | November 2021 | April 2025 | Allow | 41 | 4 | 0 | Yes | Yes |
| 17531326 | DRUG DELIVERY DEVICE INCLUDING RESERVOIR WITH FLEXIBLE LINING | November 2021 | October 2025 | Allow | 47 | 4 | 1 | No | No |
| 17520425 | CONNECTORS FOR PERITONEAL DIALYSIS | November 2021 | May 2025 | Allow | 42 | 4 | 0 | Yes | No |
| 17609058 | DEVICES FOR STORAGE AND DELIVERY OF NONPATHOGENIC MICROORGANISMS | November 2021 | May 2025 | Abandon | 43 | 1 | 0 | No | No |
| 17519295 | ANTISEPTIC CONNECTOR COVER AND METHOD OF USE | November 2021 | April 2024 | Abandon | 29 | 0 | 1 | No | No |
| 17506579 | SURGICAL HANDPIECE WITH ROTATABLE CANNULA HEAD | October 2021 | October 2025 | Abandon | 48 | 1 | 1 | Yes | No |
| 17601917 | CUTANEOUS DEVICE FOR STORING AND RELEASING MOLECULES, AND CORRESPONDING METHOD | October 2021 | December 2025 | Abandon | 50 | 2 | 1 | No | No |
| 17492607 | MONITOR, AND METHOD FOR COMBINED DISPLAY OF PHYSIOLOGICAL SIGN PARAMETERS AND MEDICATION INFORMATION FOR SAME | October 2021 | January 2026 | Allow | 51 | 3 | 0 | Yes | No |
| 17492103 | FLUID DELIVERY DEVICE HAVING MULTIPLE PENETRATING ELEMENTS | October 2021 | July 2025 | Allow | 45 | 0 | 2 | No | No |
| 17593507 | FINE NEEDLE INJECTION THERAPY DEVICE | September 2021 | February 2025 | Abandon | 41 | 0 | 1 | No | No |
| 17479862 | MULTI-CHANNEL AUTOMATIC INFUSION CONTROL DEVICE | September 2021 | May 2024 | Abandon | 32 | 1 | 0 | No | No |
| 17477821 | INJECTION DEVICE WITH A CAP FOR REMOVING A NEEDLE SHIELD CAP FROM A PRODUCT CONTAINER, AND METHOD FOR ASSEMBLING SUCH AN INJECTION DEVICE | September 2021 | November 2024 | Allow | 38 | 1 | 0 | No | No |
| 17593214 | FLUSHING VAGINAL STENT DEVICES AND RELATED SYSTEMS AND METHODS | September 2021 | September 2025 | Abandon | 48 | 2 | 0 | No | No |
| 17432581 | Applicator for Microneedle Patch | August 2021 | September 2025 | Abandon | 49 | 2 | 1 | No | No |
| 17408336 | CATHETER ASSEMBLY | August 2021 | August 2025 | Allow | 48 | 2 | 1 | Yes | No |
| 17432096 | DRUG INFUSION DEVICE | August 2021 | July 2025 | Allow | 47 | 2 | 0 | Yes | No |
| 17404455 | INSULIN DELIVERY ARRANGEMENT AND METHOD FOR INSULIN DOSING | August 2021 | March 2025 | Allow | 43 | 3 | 0 | Yes | No |
| 17310184 | ASSISTED MANUAL INJECTION DEVICE FOR INJECTING A COMPOSITION CONTAINED IN A CONTAINER | July 2021 | July 2025 | Abandon | 48 | 2 | 0 | No | No |
| 17375382 | PERICARDIAL PUNCTURE DEVICE AND METHOD | July 2021 | March 2025 | Allow | 44 | 2 | 0 | Yes | No |
| 17374213 | MODULAR ADMINISTRATION APPLIANCE | July 2021 | May 2025 | Allow | 46 | 2 | 0 | Yes | No |
| 17417419 | PORTABLE PUMP FOR DRUG INFUSION THROUGH A SYRINGE REMOVABLY ENGAGED IN THE PUMP | June 2021 | September 2025 | Allow | 51 | 3 | 0 | Yes | No |
| 17415956 | NEEDLELESS INJECTOR | June 2021 | August 2025 | Allow | 50 | 3 | 0 | Yes | No |
| 17414720 | Balloon Occlusion Catheter | June 2021 | March 2026 | Allow | 57 | 4 | 0 | Yes | No |
| 17413607 | MECHANISMS FOR PREVENTING RECONNECTION OF CONNECTORS INTENDED FOR SINGLE USE | June 2021 | November 2024 | Abandon | 41 | 0 | 1 | No | No |
| 17311194 | Drug Delivery Device and Drug Delivery System | June 2021 | March 2025 | Abandon | 45 | 1 | 1 | No | No |
| 17336912 | DEFAULT CARBOHYDRATE CONSUMPTION COUNTS BASED ON POPULATION CARBOHYDRATE CONSUMPTION MODELS | June 2021 | August 2025 | Allow | 50 | 3 | 0 | Yes | No |
| 17298773 | MYOCARDIAL PROTECTION SYSTEM | June 2021 | May 2025 | Allow | 48 | 2 | 0 | Yes | No |
| 17207416 | CATHETERIZATION APPARATUS, CATHETER, AND METHOD | March 2021 | October 2024 | Abandon | 43 | 0 | 1 | No | No |
| 17273084 | CONNECTION MEMBER, INJECTION DEVICE AND PUMP CASING EQUIPPED WITH CONNECTION MEMBER, AND LIQUID VERIFICATION METHOD USING CONNECTION MEMBER | March 2021 | November 2024 | Allow | 45 | 2 | 1 | No | No |
| 17185645 | METHOD AND DEVICES FOR RECEIVING A CANNULA | February 2021 | September 2024 | Allow | 43 | 1 | 1 | Yes | No |
| 17270373 | MEDICAL DEVICE COMPRISING AN ACTUATION ELEMENT | February 2021 | April 2025 | Allow | 49 | 3 | 0 | No | No |
| 17270126 | MEDICAL INFUSION SYSTEM | February 2021 | September 2025 | Abandon | 55 | 5 | 0 | No | No |
| 17270177 | Improved Metering Mechanism and Injection Device | February 2021 | March 2025 | Allow | 49 | 3 | 0 | Yes | No |
| 17266513 | SYSTEM, DEVICE, AND METHOD FOR VASCULAR ACCESS | February 2021 | January 2025 | Abandon | 48 | 2 | 1 | No | No |
| 17266423 | MEDICATION DELIVERY DEVICE WITH DOSE DETECTION SYSTEM | February 2021 | April 2025 | Allow | 51 | 3 | 1 | No | No |
| 17263478 | ADMINISTRATION SYSTEM COMPRISING AN ADMINISTRATION DEVICE AND A PROTECTIVE DEVICE PROVIDED WITH A CLOSURE MEMBRANE | January 2021 | August 2024 | Abandon | 43 | 1 | 0 | No | No |
| 17149398 | SYSTEM AND METHOD FOR DETECTING ISSUES IN THE BASAL RATE IN INSULIN TREATED DIABETES PATIENTS | January 2021 | July 2025 | Allow | 54 | 3 | 0 | Yes | No |
| 17260400 | Cartridge Assembly for a Drug Delivery Device and Drug Delivery Device | January 2021 | September 2024 | Allow | 44 | 2 | 1 | No | No |
| 17259532 | SYSTEMS AND METHODS FOR PROVIDING DISTAL EMBOLIC PROTECTION | January 2021 | December 2025 | Abandon | 59 | 3 | 1 | No | No |
| 17258785 | Cartridge Unit for a Drug Delivery Device | January 2021 | November 2024 | Allow | 46 | 2 | 1 | Yes | No |
| 17258699 | CARTRIDGE ASSEMBLY AND METHOD FOR ASSEMBLING THE SAME | January 2021 | August 2024 | Allow | 44 | 2 | 1 | No | No |
| 17257644 | PORTABLE AUTO INJECTION APPARATUS WITH SHORT LENGTH | January 2021 | June 2024 | Abandon | 41 | 1 | 0 | No | No |
| 17256568 | CHEMICAL LIQUID INJECTING APPARATUS | December 2020 | August 2025 | Allow | 56 | 4 | 0 | Yes | No |
| 17256214 | EPIDURAL DELIVERY DEVICE | December 2020 | August 2025 | Abandon | 56 | 3 | 0 | No | No |
| 16972587 | Improvements in, or relating to, applicators | December 2020 | June 2024 | Allow | 42 | 2 | 0 | No | No |
| 16972511 | SAFETY CAP | December 2020 | December 2025 | Allow | 60 | 5 | 1 | Yes | No |
| 17056125 | SENSOR ASSEMBLY WITH IDENTIFIER DETERMINATION | November 2020 | February 2026 | Allow | 60 | 4 | 1 | No | Yes |
| 17045840 | Universal Single-Use Cap For Male And Female Connectors | October 2020 | February 2025 | Allow | 52 | 4 | 0 | Yes | No |
| 17045817 | Medical Injection System | October 2020 | January 2024 | Allow | 40 | 1 | 0 | No | No |
| 16976102 | INTRAVASCULAR PORT BASED SENSING AND TREATMENT SYSTEM | August 2020 | May 2024 | Abandon | 44 | 1 | 0 | No | No |
| 16603543 | CHEMICAL LIQUID INJECTOR | October 2019 | August 2024 | Allow | 59 | 2 | 0 | No | No |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner TURKOWSKI, KAYLA MARIE.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 33.3% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is above the USPTO average, suggesting that filing an appeal can be an effective strategy for prompting reconsideration.
✓ Filing a Notice of Appeal is strategically valuable. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.
Examiner TURKOWSKI, KAYLA MARIE works in Art Unit 3783 and has examined 56 patent applications in our dataset. With an allowance rate of 62.5%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 47 months.
Examiner TURKOWSKI, KAYLA MARIE's allowance rate of 62.5% places them in the 23% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.
On average, applications examined by TURKOWSKI, KAYLA MARIE receive 2.29 office actions before reaching final disposition. This places the examiner in the 64% percentile for office actions issued. This examiner issues a slightly above-average number of office actions.
The median time to disposition (half-life) for applications examined by TURKOWSKI, KAYLA MARIE is 47 months. This places the examiner in the 10% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.
Conducting an examiner interview provides a +58.3% benefit to allowance rate for applications examined by TURKOWSKI, KAYLA MARIE. This interview benefit is in the 96% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.
When applicants file an RCE with this examiner, 34.2% of applications are subsequently allowed. This success rate is in the 75% percentile among all examiners. Strategic Insight: RCEs are highly effective with this examiner compared to others. If you receive a final rejection, filing an RCE with substantive amendments or arguments has a strong likelihood of success.
This examiner enters after-final amendments leading to allowance in 15.8% of cases where such amendments are filed. This entry rate is in the 17% percentile among all examiners. Strategic Recommendation: This examiner rarely enters after-final amendments compared to other examiners. You should generally plan to file an RCE or appeal rather than relying on after-final amendment entry. Per MPEP § 714.12, primary examiners have discretion in entering after-final amendments, and this examiner exercises that discretion conservatively.
When applicants request a pre-appeal conference (PAC) with this examiner, 200.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 99% percentile among all examiners. Strategic Recommendation: Pre-appeal conferences are highly effective with this examiner compared to others. Before filing a full appeal brief, strongly consider requesting a PAC. The PAC provides an opportunity for the examiner and supervisory personnel to reconsider the rejection before the case proceeds to the PTAB.
This examiner withdraws rejections or reopens prosecution in 100.0% of appeals filed. This is in the 99% percentile among all examiners. Of these withdrawals, 100.0% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner frequently reconsiders rejections during the appeal process compared to other examiners. Per MPEP § 1207.01, all appeals must go through a mandatory appeal conference. Filing a Notice of Appeal may prompt favorable reconsideration even before you file an Appeal Brief.
When applicants file petitions regarding this examiner's actions, 120.0% are granted (fully or in part). This grant rate is in the 95% percentile among all examiners. Strategic Note: Petitions are frequently granted regarding this examiner's actions compared to other examiners. Per MPEP § 1002.02(c), various examiner actions are petitionable to the Technology Center Director, including prematureness of final rejection, refusal to enter amendments, and requirement for information. If you believe an examiner action is improper, consider filing a petition.
Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 47% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 5.7% of allowed cases (in the 82% percentile). Per MPEP § 714.14, a Quayle action indicates that all claims are allowable but formal matters remain. This examiner frequently uses Quayle actions compared to other examiners, which is a positive indicator that once substantive issues are resolved, allowance follows quickly.
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.